Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Putter

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
The British Journal of Surgery|August 13, 2009
Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgeryM den Dulk, C A M Marijnen, L Collette, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2009
Risk factors for sexual dysfunction after rectal cancer treatmentM M Lange, C A M Marijnen, C P Maas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 27, 2016
Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04)D B Y Fontein, A Charehbili, J W R Nortier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2015
Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trialD B Y Fontein, M Klinten Grand, J W R Nortier, et al.
The British Journal of Surgery|June 16, 2009
Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancerM M Lange, J A van Hilten, L M G van de Watering, et al.
ESMO Open|September 15, 2023
Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does notW H Zwart, E A Dijkstra, H Putter, et al.
ESMO Open|October 22, 2023
Corrigendum to "Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not": [ESMO Open 8 (2023) 101645]W H Zwart, E A Dijkstra, H Putter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 29, 2022
Authors' reply-A sensitivity analysis of the RAPIDO clinical trialE A Dijkstra, W H Zwart, H Putter, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 19, 2012
Use of different comorbidity scores for risk-adjustment in the evaluation of quality of colorectal cancer surgery: does it matter?J W T Dekker, G A Gooiker, L G M van der Geest, et al.
Bone Marrow Transplantation|October 3, 2017
Donor T-cell responses and disease progression patterns of multiple myelomaM Eefting, L C de Wreede, P A Von dem Borne, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
The British Journal of Surgery|August 13, 2009
Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgeryM den Dulk, C A M Marijnen, L Collette, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2009
Risk factors for sexual dysfunction after rectal cancer treatmentM M Lange, C A M Marijnen, C P Maas, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 27, 2016
Specific adverse events are associated with response to exemestane therapy in postmenopausal breast cancer patients: Results from the TEAMIIA study (BOOG2006-04)D B Y Fontein, A Charehbili, J W R Nortier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2015
Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trialD B Y Fontein, M Klinten Grand, J W R Nortier, et al.
The British Journal of Surgery|June 16, 2009
Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancerM M Lange, J A van Hilten, L M G van de Watering, et al.
ESMO Open|September 15, 2023
Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does notW H Zwart, E A Dijkstra, H Putter, et al.
ESMO Open|October 22, 2023
Corrigendum to "Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not": [ESMO Open 8 (2023) 101645]W H Zwart, E A Dijkstra, H Putter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 29, 2022
Authors' reply-A sensitivity analysis of the RAPIDO clinical trialE A Dijkstra, W H Zwart, H Putter, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 19, 2012
Use of different comorbidity scores for risk-adjustment in the evaluation of quality of colorectal cancer surgery: does it matter?J W T Dekker, G A Gooiker, L G M van der Geest, et al.
Bone Marrow Transplantation|October 3, 2017
Donor T-cell responses and disease progression patterns of multiple myelomaM Eefting, L C de Wreede, P A Von dem Borne, et al.
Pageof 16